Matthew Rosebraugh

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

Julie Parmentier, J W Voss, Candace Graff et al. · BMC Rheumatology · 2018 · 374 citations · Full text

Medicine, Immunology, Pharmacology +16

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease

Matthew Rosebraugh, Eric A. Voight, Ehab M. Moussa et al. · Annals of Neurology · 2021 · 83 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion

Matthew Rosebraugh, Wei Liu, Melina Neenan et al. · Journal of Parkinson s Disease · 2021 · 70 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia

Matthew Rosebraugh, John A. Widness, Demet Nalbant et al. · Transfusion · 2012 · 51 citations · Full text

Medicine, Hematology, Pediatrics +17

Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum

Matthew Rosebraugh, Sven Stodtmann, Wei Liu et al. · Parkinsonism & Related Disorders · 2022 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +10